Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

348 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
P2Y12 inhibitors in acute coronary syndrome patients with renal dysfunction: an analysis from the RENAMI and BleeMACS projects.
De Filippo O, D'Ascenzo F, Raposeiras-Roubin S, Abu-Assi E, Peyracchia M, Bocchino PP, Kinnaird T, Ariza-Solé A, Liebetrau C, Manzano-Fernández S, Boccuzzi G, Henriques JPS, Templin C, Wilton SB, Omedè P, Velicki L, Xanthopoulou I, Correia L, Cerrato E, Rognoni A, Fabrizio U, Nuñez-Gil I, Iannaccone M, Montabone A, Taha S, Fujii T, Durante A, Song X, Gili S, Magnani G, Varbella F, Kawaji T, Blanco PF, Garay A, Quadri G, Alexopoulos D, Caneiro Queija B, Huczek Z, Cobas Paz R, González Juanatey JR, Cespón Fernández M, Nie SP, Muñoz Pousa I, Kawashiri MA, Gallo D, Morbiducci U, Conrotto F, Montefusco A, Dominguez-Rodriguez A, López-Cuenca A, Cequier A, Iñiguez-Romo A, Usmiani T, Rinaldi M, De Ferrari GM. De Filippo O, et al. Eur Heart J Cardiovasc Pharmacother. 2020 Jan 1;6(1):31-42. doi: 10.1093/ehjcvp/pvz048. Eur Heart J Cardiovasc Pharmacother. 2020. PMID: 31511896 Free article.
Randomised, double-blind, placebo-controlled trial of ivabradine in patients with acute coronary syndrome: effects of the If current inhibitor ivabradine on reduction of inflammation markers in patients with acute coronary syndrome--RIVIERA trial study design and rationale.
Dominguez-Rodriguez A, Fard SS, Abreu-Gonzalez P, Bosa-Ojeda F, Consuegra-Sanchez L, Jiménez-Sosa A, Grande AS, Kaski JC. Dominguez-Rodriguez A, et al. Cardiovasc Drugs Ther. 2009 Jun;23(3):243-7. doi: 10.1007/s10557-009-6164-9. Epub 2009 Feb 20. Cardiovasc Drugs Ther. 2009. PMID: 19229603 Clinical Trial.
[Differential characteristics of patients with acute coronary syndrome without ST-segment elevation compared to those with transient ST-segment elevation].
Arroyo Úcar E, Domínguez-Rodríguez A, Juárez Prera R, Blanco Palacios G, Hernández García C, Carrillo-Pérez Tome M, Abreu-González P. Arroyo Úcar E, et al. Med Intensiva. 2011 Jun-Jul;35(5):270-3. doi: 10.1016/j.medin.2011.01.007. Epub 2011 Feb 24. Med Intensiva. 2011. PMID: 21353340 Free article. Spanish.
Anemia in patients with acute coronary syndromes treated with prasugrel or ticagrelor: Insights from the RENAMI registry.
Guerrero C, Garay A, Ariza-Solé A, Formiga F, Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Kinnaird T, Manzano-Fernández S, Alegre O, Sánchez-Salado JC, Lorente V, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Conrotto F, Bertaina M, Autelli M, Grosso A, Blanco PF, Quadri G, Varbella F, Tomassini F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Alexopoulos D, Iñiguez-Romo A, Gaita F, Cequier Á. Guerrero C, et al. Thromb Res. 2018 Jul;167:142-148. doi: 10.1016/j.thromres.2018.05.024. Epub 2018 May 22. Thromb Res. 2018. PMID: 29857270
Annual Incidence of Confirmed Stent Thrombosis and Clinical Predictors in Patients With ACS Treated With Ticagrelor or Prasugrel.
Raposeiras-Roubín S, Abu-Assi E, D'Ascenzo F, Fernández-Barbeira S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tommassini F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A. Raposeiras-Roubín S, et al. Rev Esp Cardiol (Engl Ed). 2019 Apr;72(4):298-304. doi: 10.1016/j.rec.2018.05.021. Epub 2018 Jun 25. Rev Esp Cardiol (Engl Ed). 2019. PMID: 29954720 English, Spanish.
Usefulness of the PARIS Score to Evaluate the Ischemic-hemorrhagic Net Benefit With Ticagrelor and Prasugrel After an Acute Coronary Syndrome.
Raposeiras-Roubín S, Caneiro Queija B, D'Ascenzo F, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Quadri G, Rognoni A, Boccuzzi G, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Varbella F, Tomassini F, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Domínguez-Rodríguez A, Baz-Alonso JA, Calvo-Iglesias F, Valdés M, Cequier Á, Gaita F, Alexopoulos D, Íñiguez-Romo A, Abu-Assi E. Raposeiras-Roubín S, et al. Rev Esp Cardiol (Engl Ed). 2019 Mar;72(3):215-223. doi: 10.1016/j.rec.2018.06.004. Epub 2018 Jul 18. Rev Esp Cardiol (Engl Ed). 2019. PMID: 30029980 English, Spanish.
Incidence and predictors of bleeding in ACS patients treated with PCI and prasugrel or ticagrelor: An analysis from the RENAMI registry.
D'Ascenzo F, Grosso A, Abu-Assi E, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Ali HH, Magnani G, Autelli M, Blanco PF, Garay A, Quadri G, Marra WG, Varbella F, Queija BC, Paz RC, Fernández MC, Pousa IM, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Raposeiras-Roubin S. D'Ascenzo F, et al. Int J Cardiol. 2018 Dec 15;273:29-33. doi: 10.1016/j.ijcard.2018.09.020. Epub 2018 Sep 6. Int J Cardiol. 2018. PMID: 30228021
Prasugrel or ticagrelor in patients with acute coronary syndrome and diabetes: a propensity matched substudy of RENAMI.
Conrotto F, Bertaina M, Raposeiras-Roubin S, Kinnaird T, Ariza-Solé A, Manzano-Fernández S, Templin C, Velicki L, Xanthopoulou I, Cerrato E, Rognoni A, Boccuzzi G, Omedè P, Montabone A, Taha S, Durante A, Gili S, Magnani G, Autelli M, Grosso A, Flores Blanco P, Garay A, Quadri G, Varbella F, Caneiro Queija B, Cobas Paz R, Cespón Fernández M, Muñoz Pousa I, Gallo D, Morbiducci U, Dominguez-Rodriguez A, Valdés M, Cequier A, Alexopoulos D, Iñiguez-Romo A, Gaita F, Abu-Assi E, D'Ascenzo F. Conrotto F, et al. Eur Heart J Acute Cardiovasc Care. 2019 Sep;8(6):536-542. doi: 10.1177/2048872618802783. Epub 2018 Oct 1. Eur Heart J Acute Cardiovasc Care. 2019. PMID: 30270638
348 results